Inventor · disambiguated record
Gail Farfel
Also filed as: FARFEL GAIL M · FARFEL Gail
0 granted patents·11 pending applications·0 citations·filing 2017–2022
Files withZOGENIX INTERNATIONAL LTD11
Top patents by PatentIndex Score
11 records- 0176US2022370381A1Compositions and methods for treating seizure disordersZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 0275US2023076320A1Norfenfluramine to treat dravet syndromeZOGENIX INTERNATIONAL LTD·Filed 2022·Application pending·0 cites
- 0373US2019091174A1Method of reducing seizure type experienced by a dravet patientZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 0467US2019091173A1Method of increasing time between convulsive seizuresZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 0567US2020297665A1Compositions and methods for treating seizure disordersZOGENIX INTERNATIONAL LTD·Filed 2020·Application pending·0 cites
- 0667US2019125697A1Method of reduction in convulsive seizure frequencyZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 0766US2018092864A1Compositions and methods for treating seizure disordersZOGENIX INTERNATIONAL LTD·Filed 2017·Application pending·0 cites
- 0864US2019091175A1Method of reduction medication in treating dravet syndromeZOGENIX INTERNATIONAL LTD·Filed 2018·Application pending·0 cites
- 0953US2021113495A1Method of treating epilepsy or epileptic encephalopathy with fenfluramine in patients without pulmonary hypertensionZOGENIX INTERNATIONAL LTD·Filed 2019·Application pending·0 cites
- 1046US2019247333A1Method of reduction in convulsive seizure frequencyZOGENIX INTERNATIONAL LTD·Filed 2019·Application pending·0 cites
- 1144US2021137853A1Methods of treating epileptic patients with fenfluramineZOGENIX INTERNATIONAL LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gail Farfel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →